OR13D1

Across TCGA pan-cancer cohorts, OR13D1 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated OR13D1 data layer compared with 11 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher OR13D1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OR13D1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LUAD, UCEC, and SKCM are the cancer types where OR13D1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	0.004	0.751	<.001	24	view →
UCEC	DFS	Median	All	1.000	0.622	.019	12	view →
SKCM	DFS	Median	II,III,IV	0.016	0.709	<.001	9	view →
ACC	OS	Median	All	0.118	0.624	.038	6	view →
LUSC	DFS	Median	II,III,IV	0.204	0.614	.007	6	view →
COAD	OS	Median	All	0.216	0.678	.038	2	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

OR13D1–LUAD (OS)

Open the LUAD breakdown →